Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lessons for COVID-19 Immunity from Other Coronavirus Infections
Alan Sariol, Stanley Perlman
Immunity (2020) Vol. 53, Iss. 2, pp. 248-263
Open Access | Times Cited: 332

Showing 1-25 of 332 citing articles:

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan, José Mateus, Yu Kato, et al.
Science (2021) Vol. 371, Iss. 6529
Open Access | Times Cited: 2727
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1055
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 615-632
Open Access | Times Cited: 1022
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
Rogan A. Grant, Luisa Morales‐Nebreda, Nikolay S. Markov, et al.
Nature (2021) Vol. 590, Iss. 7847, pp. 635-641
Open Access | Times Cited: 655
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
Cell (2021) Vol. 184, Iss. 8, pp. 2201-2211.e7
Open Access | Times Cited: 513
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra L. Klein, Andrew Pekosz, Han-Sol Park, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 6141-6150
Open Access | Times Cited: 444
The dawn of mRNA vaccines: The COVID-19 case
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 511-520
Open Access | Times Cited: 385
Recent endemic coronavirus infection is associated with less-severe COVID-19
Manish Sagar, Katherine Reifler, Michael R. Rossi, et al.
Journal of Clinical Investigation (2020) Vol. 131, Iss. 1
Open Access | Times Cited: 318
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Aurélien Sokal, Pascal Chappert, Giovanna Barba‐Spaeth, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1201-1213.e14
Open Access | Times Cited: 312
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward, Philipe Gobeil, Annie Séguin, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1071-1078
Open Access | Times Cited: 269
Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study
Brody H. Foy, Brian Wahl, Kayur Mehta, et al.
International Journal of Infectious Diseases (2020) Vol. 103, pp. 431-438
Open Access | Times Cited: 237
Vaccines for COVID-19
John S. Tregoning, E. Sherwood Brown, Hannah M. Cheeseman, et al.
Clinical & Experimental Immunology (2020) Vol. 202, Iss. 2, pp. 162-192
Open Access | Times Cited: 215
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
Agnes Bonifacius, Sabine Tischer‐Zimmermann, Anna Christina Dragon, et al.
Immunity (2021) Vol. 54, Iss. 2, pp. 340-354.e6
Open Access | Times Cited: 203
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
Corey A. Siegel, Gil Y. Melmed, Dermot McGovern, et al.
Gut (2021) Vol. 70, Iss. 4, pp. 635-640
Open Access | Times Cited: 181
Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection
Min Zheng, Evan P. Williams, R. K. Subbarao Malireddi, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 41, pp. 14040-14052
Open Access | Times Cited: 171
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 139
Antibody and B cell responses to SARS-CoV-2 infection and vaccination
Katharina Röltgen, Scott D. Boyd
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1063-1075
Open Access | Times Cited: 128
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García‐Montero, Óscar Fraile-Martínez, Coral Bravo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 104
Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection
Yang Yang, Minghui Yang, Yun Peng, et al.
Nature Microbiology (2022) Vol. 7, Iss. 3, pp. 423-433
Open Access | Times Cited: 104
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 98
Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity
Alberto Domingo López-Muñoz, Ivan Košík, Jaroslav Hollý, et al.
Science Advances (2022) Vol. 8, Iss. 31
Open Access | Times Cited: 88
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection
Jennifer M. Dan, José Mateus, Yu Kato, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 122
Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation
Charles M. King, Jonathan Sprent
Trends in Immunology (2021) Vol. 42, Iss. 4, pp. 312-322
Open Access | Times Cited: 99
The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
Ahmed Babiker, Charles Marvil, Jesse J. Waggoner, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 4
Open Access | Times Cited: 95
Page 1 - Next Page

Scroll to top